Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensus

AIM: To stablish a consensus on the treatment strategy for advanced non–small-cell lung cancer (aNSCLC) with epidermal growth factor receptor mutation (EGFRm) in Spain. METHODS: After a systematic literature review, the scientific committee developed 33 statements in 4 fields: molecular diagnosis (1...

Descripción completa

Detalles Bibliográficos
Autores principales: Isla, D., de Castro, J., García-Campelo, R., Majem, M., Vicente, D., Juan-Vidal, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192379/
https://www.ncbi.nlm.nih.gov/pubmed/33210237
http://dx.doi.org/10.1007/s12094-020-02518-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192379/
https://www.ncbi.nlm.nih.gov/pubmed/33210237
http://dx.doi.org/10.1007/s12094-020-02518-0

Ejemplares similares